CDLX
Cardlytics Inc
3.60$
-2.7%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 54.6% | 55.7% | 54.3% | 58.8% | 57.4% | 55.8% | 59.4% | 53.7% | 53.3% | 53.8% | 50.1% | 49.5% | 52.1% | |
| 45.4% | 44.3% | 45.7% | 41.2% | 42.6% | 44.2% | 40.6% | 46.3% | 46.7% | 46.2% | 49.9% | 50.5% | 47.9% | |
| 15.7% | 14.0% | 19.3% | 19.3% | 19.7% | 13.4% | 18.9% | 17.9% | 16.9% | 14.2% | 18.7% | 15.0% | 16.0% | |
| 19.7% | 29.7% | 21.4% | 23.2% | 18.0% | 18.6% | 22.3% | 20.4% | 20.9% | 24.7% | 24.1% | 21.3% | 22.8% | |
| 71.5% | 159.7% | 79.5% | 63.9% | 264.1% | 55.5% | 63.4% | 66.5% | 179.0% | 53.5% | 74.1% | 65.2% | 96.3% | |
| -26.1% | -115.4% | -33.8% | -22.7% | -221.5% | -11.2% | -22.7% | -20.2% | -132.3% | -7.3% | -24.1% | -14.8% | -48.3% | |
| 2.2% | 1.9% | 2.6% | 3.5% | 3.5% | 3.2% | 3.8% | 3.7% | 5.6% | 5.3% | 8.1% | 6.2% | 6.1% | |
| -30.3% | -113.1% | -35.9% | -6.1% | -216.5% | -21.1% | -21.5% | -14.7% | -139.7% | -14.7% | -40.2% | -23.5% | -57.6% | |
| 2.2% | 113.1% | 10.0% | 6.1% | 216.5% | 0.0% | – | – | – | – | -27.2% | – | – | |
| -30.3% | -113.1% | -35.9% | -6.1% | -216.5% | -21.1% | -21.5% | -14.7% | -139.7% | -14.7% | -13.1% | -40.3% | -55.9% | |
| -19.8% | -103.4% | -23.3% | 7.5% | -201.8% | -9.1% | -6.4% | 0.0% | -121.6% | 2.3% | -18.2% | -6.3% | -39.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.